Cancerous drug
The German pharmaceutical giant Schering AG is in for a hard time. Androcur and Diane 35, 2 of its best-selling drugs marketed in Europe, are suspected to be potential causes of cancer. Tests carried out on rodents by the Federal Institute for Medication and Medical Products revealed a possible carcinogenic effect from a substance called cypoteron-acetate in the drugs. Consequently, in mid-August, German health authorities asked the company to retest the drugs. A Schering spokesperson, however, says that "you can't make any connection to humans from those tests".
Related Content
- Order of the High Court of Kerala regarding pricing of breast cancer medicines, 02/11/2023
- WHO report on cancer- setting priorities, investing wisely & providing care for all
- New method for controlled-release makes cancer drugs less toxic to healthy tissues
- Rajasthan health dept to hire for free medicine scheme
- Top drugmakers not doing enough to provide medicines to poor countries: Report
- Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways